CEDEER/SOR Webinar: What’s the Latest? Psychedelics for Opioid Use Disorder (March 30, 12pm PT)
03/10/2026
Interest in the therapeutic use of psychedelics has grown rapidly in recent years—but what does the emerging research indicate about their role in treating opioid use disorder (OUD)?
In this session, presented by Nathan Sackett, MD, MS, of ADAI’s Center for Novel Therapeutics in Addiction Psychiatry, we’ll explore the current evidence, potential mechanisms, safety considerations, and the possible future of psychedelic treatment approaches in OUD care.
About the speaker
Dr. Nathan Sackett is an addiction psychiatrist, faculty member in the Department of Psychiatry and Behavioral Sciences, and Director for the Center for Novel Therapeutics in Addiction Psychiatry at the University of Washington. He provides outpatient care for patients with psychiatric, and substance use disorders and conducts research on the use of psychedelics to support behavior change and enhance psychotherapy.
